Airmid   Phone: (650) 368 6983
info@airmid.com
   
February 2011
February 2011 AIRMID partners with Circassia to develop topical PAP-1
January 2010
Joe Sum joins AIRMID Board of Directors
July 2009
AIRMID partners with Kineta
to develop ShK peptides

more...
 
Airmid Incorporated
George Miljanich PhD,
CEO
600 Castle Hill Road
Redwood City, CA 94061
gmiljanich@comcast.net
650-368-6983
650-269-7078
 
AIRMID is seeking a committed development partner for its promising autoimmune treatment, PAP-1
Oral MULTIPLE SCLEROSIS, psoriasis AND/OR TYPE 1 DIABETES drug
SUPPOSITORY CROHN'S DISEASE drug